MELBOURNE, Australia and SINGAPORE, Dec. 07, 2025 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced a significant expansion of its VALLAURIX Research, Development and Innovation (RD&I) ...
core focus on accelerating development of liquid long-acting drug delivery platforms existing RD&I teams will advance late-stage development programs without disruption strategic investment supported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results